An acute ischemic stroke (AIS) triggers rapid mobilization of immune cells from bone marrow, leading to the infiltration of circulating immune cells into the brain. Among these immune cells, monocytes, which are pivotal in both adaptive and innate immune responses, play a crucial role in stroke injury and recovery in a temporal manner. Previous research indicates that tissue injury such as AIS causes acute monocytosis. However, it remains unclear if this upregulation persists during the recovery phase. Given the diverse roles of monocytes during post-stroke recovery, we hypothesize that their numbers remain elevated during chronic recovery. In this study, we will analyze the effect of stroke duration on monocytosis and the factors affecting this process after AIS. We recruited consecutive AIS patients (58-90 years) undergoing endovascular clot retrieval and age-matched healthy control subjects of both sexes, with informed consent obtained from all participants. Flow cytometric analysis of whole blood-derived immune cells, including monocytes, was performed at 0–2 days (acute, n=20), 3–7 days (subacute, n=20), and 65±20 days (chronic, n=14) after stroke onset. These were compared with healthy subjects (n=20 per age group). A pure monocyte population was isolated using a side and forward scatter plot with cell-surface markers, such as HLA-DR, CD45, CD11b, CD14, and CD16, along with a negative gating strategy. Plasma samples were analyzed for various secreted cytokine levels using the Millipore multiplex array. scRNA-seq analysis was employed to support the evidence of monocytosis using total immune cells of these subjects. We found that the total monocyte count (% of total immune cells) progressively increased during recovery in AIS patients (P<0.05), which was corroborated by unbiased scRNA-seq analysis data. Cytokine analysis indicated that the levels of M-CSF and G-CSF also progressively increased, further supporting the evidence of monocytosis after stroke. Subclassification of monocyte clusters from RNA-seq data suggested that specific monocyte subsets are the major contributors to monocytosis. In summary, our data support the evidence of continued monocytosis after ischemic stroke, indicating diverse roles for monocytes beyond the acute inflammatory response. Detailed molecular characterization of monocytes, their subpopulations, and their genetic composition over time may provide novel insights into their pathophysiological roles during stroke recovery.
Read full abstract